Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Transcriptomic and proteomic approaches reveal biological basis of intraoperative radiotherapy-treated tumor bed modification in breast cancer patients: A pilot study.

Shahani M, Shakeri J, Akbari ME, Arefnezhad B, Tafti A, Zali H, Nafisi N, Hashemi M, Rezaei-Tavirani M, Mohammadpour S, Salami SAR, Mirzai HR, Samsami M, Ezabady SHJ, Akbari A.

J Proteomics. 2019 Nov 21;212:103596. doi: 10.1016/j.jprot.2019.103596. [Epub ahead of print]

PMID:
31759177
2.

Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study.

Osmani F, Hajizadeh E, Rasekhi A, Akbari ME.

Breast. 2019 Dec;48:82-88. doi: 10.1016/j.breast.2019.09.010. Epub 2019 Sep 18.

PMID:
31568898
3.

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O, Abdelalim A, Abdoli A, Abdollahpour I, Abdulle ASM, Abebe ND, Abraha HN, Abu-Raddad LJ, Abualhasan A, Adedeji IA, Advani SM, Afarideh M, Afshari M, Aghaali M, Agius D, Agrawal S, Ahmadi A, Ahmadian E, Ahmadpour E, Ahmed MB, Akbari ME, Akinyemiju T, Al-Aly Z, AlAbdulKader AM, Alahdab F, Alam T, Alamene GM, Alemnew BTT, Alene KA, Alinia C, Alipour V, Aljunid SM, Bakeshei FA, Almadi MAH, Almasi-Hashiani A, Alsharif U, Alsowaidi S, Alvis-Guzman N, Amini E, Amini S, Amoako YA, Anbari Z, Anber NH, Andrei CL, Anjomshoa M, Ansari F, Ansariadi A, Appiah SCY, Arab-Zozani M, Arabloo J, Arefi Z, Aremu O, Areri HA, Artaman A, Asayesh H, Asfaw ET, Ashagre AF, Assadi R, Ataeinia B, Atalay HT, Ataro Z, Atique S, Ausloos M, Avila-Burgos L, Avokpaho EFGA, Awasthi A, Awoke N, Ayala Quintanilla BP, Ayanore MA, Ayele HT, Babaee E, Bacha U, Badawi A, Bagherzadeh M, Bagli E, Balakrishnan S, Balouchi A, Bärnighausen TW, Battista RJ, Behzadifar M, Behzadifar M, Bekele BB, Belay YB, Belayneh YM, Berfield KKS, Berhane A, Bernabe E, Beuran M, Bhakta N, Bhattacharyya K, Biadgo B, Bijani A, Bin Sayeed MS, Birungi C, Bisignano C, Bitew H, Bjørge T, Bleyer A, Bogale KA, Bojia HA, Borzì AM, Bosetti C, Bou-Orm IR, Brenner H, Brewer JD, Briko AN, Briko NI, Bustamante-Teixeira MT, Butt ZA, Carreras G, Carrero JJ, Carvalho F, Castro C, Castro F, Catalá-López F, Cerin E, Chaiah Y, Chanie WF, Chattu VK, Chaturvedi P, Chauhan NS, Chehrazi M, Chiang PP, Chichiabellu TY, Chido-Amajuoyi OG, Chimed-Ochir O, Choi JJ, Christopher DJ, Chu DT, Constantin MM, Costa VM, Crocetti E, Crowe CS, Curado MP, Dahlawi SMA, Damiani G, Darwish AH, Daryani A, das Neves J, Demeke FM, Demis AB, Demissie BW, Demoz GT, Denova-Gutiérrez E, Derakhshani A, Deribe KS, Desai R, Desalegn BB, Desta M, Dey S, Dharmaratne SD, Dhimal M, Diaz D, Dinberu MTT, Djalalinia S, Doku DT, Drake TM, Dubey M, Dubljanin E, Duken EE, Ebrahimi H, Effiong A, Eftekhari A, El Sayed I, Zaki MES, El-Jaafary SI, El-Khatib Z, Elemineh DA, Elkout H, Ellenbogen RG, Elsharkawy A, Emamian MH, Endalew DA, Endries AY, Eshrati B, Fadhil I, Fallah V, Faramarzi M, Farhangi MA, Farioli A, Farzadfar F, Fentahun N, Fernandes E, Feyissa GT, Filip I, Fischer F, Fisher JL, Force LM, Foroutan M, Freitas M, Fukumoto T, Futran ND, Gallus S, Gankpe FG, Gayesa RT, Gebrehiwot TT, Gebremeskel GG, Gedefaw GA, Gelaw BK, Geta B, Getachew S, Gezae KE, Ghafourifard M, Ghajar A, Ghashghaee A, Gholamian A, Gill PS, Ginindza TTG, Girmay A, Gizaw M, Gomez RS, Gopalani SV, Gorini G, Goulart BNG, Grada A, Ribeiro Guerra M, Guimaraes ALS, Gupta PC, Gupta R, Hadkhale K, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Hanfore LK, Haro JM, Hasankhani M, Hasanzadeh A, Hassen HY, Hay RJ, Hay SI, Henok A, Henry NJ, Herteliu C, Hidru HD, Hoang CL, Hole MK, Hoogar P, Horita N, Hosgood HD, Hosseini M, Hosseinzadeh M, Hostiuc M, Hostiuc S, Househ M, Hussen MM, Ileanu B, Ilic MD, Innos K, Irvani SSN, Iseh KR, Islam SMS, Islami F, Jafari Balalami N, Jafarinia M, Jahangiry L, Jahani MA, Jahanmehr N, Jakovljevic M, James SL, Javanbakht M, Jayaraman S, Jee SH, Jenabi E, Jha RP, Jonas JB, Jonnagaddala J, Joo T, Jungari SB, Jürisson M, Kabir A, Kamangar F, Karch A, Karimi N, Karimian A, Kasaeian A, Kasahun GG, Kassa B, Kassa TD, Kassaw MW, Kaul A, Keiyoro PN, Kelbore AG, Kerbo AA, Khader YS, Khalilarjmandi M, Khan EA, Khan G, Khang YH, Khatab K, Khater A, Khayamzadeh M, Khazaee-Pool M, Khazaei S, Khoja AT, Khosravi MH, Khubchandani J, Kianipour N, Kim D, Kim YJ, Kisa A, Kisa S, Kissimova-Skarbek K, Komaki H, Koyanagi A, Krohn KJ, Bicer BK, Kugbey N, Kumar V, Kuupiel D, La Vecchia C, Lad DP, Lake EA, Lakew AM, Lal DK, Lami FH, Lan Q, Lasrado S, Lauriola P, Lazarus JV, Leigh J, Leshargie CT, Liao Y, Limenih MA, Listl S, Lopez AD, Lopukhov PD, Lunevicius R, Madadin M, Magdeldin S, El Razek HMA, Majeed A, Maleki A, Malekzadeh R, Manafi A, Manafi N, Manamo WA, Mansourian M, Mansournia MA, Mantovani LG, Maroufizadeh S, Martini SMS, Mashamba-Thompson TP, Massenburg BB, Maswabi MT, Mathur MR, McAlinden C, McKee M, Meheretu HAA, Mehrotra R, Mehta V, Meier T, Melaku YA, Meles GG, Meles HG, Melese A, Melku M, Memiah PTN, Mendoza W, Menezes RG, Merat S, Meretoja TJ, Mestrovic T, Miazgowski B, Miazgowski T, Mihretie KMM, Miller TR, Mills EJ, Mir SM, Mirzaei H, Mirzaei HR, Mishra R, Moazen B, Mohammad DK, Mohammad KA, Mohammad Y, Darwesh AM, Mohammadbeigi A, Mohammadi H, Mohammadi M, Mohammadian M, Mohammadian-Hafshejani A, Mohammadoo-Khorasani M, Mohammadpourhodki R, Mohammed AS, Mohammed JA, Mohammed S, Mohebi F, Mokdad AH, Monasta L, Moodley Y, Moosazadeh M, Moossavi M, Moradi G, Moradi-Joo M, Moradi-Lakeh M, Moradpour F, Morawska L, Morgado-da-Costa J, Morisaki N, Morrison SD, Mosapour A, Mousavi SM, Muche AA, Muhammed OSS, Musa J, Nabhan AR, Naderi M, Nagarajan AJ, Nagel G, Nahvijou A, Naik G, Najafi F, Naldi L, Nam HS, Nasiri N, Nazari J, Negoi I, Neupane S, Newcomb PA, Nggada HA, Ngunjiri JW, Nguyen CT, Nikniaz L, Ningrum DNA, Nirayo YL, Nixon MR, Nnaji CA, Nojomi M, Nosratnejad S, Shiadeh MN, Obsa MS, Ofori-Asenso R, Ogbo FA, Oh IH, Olagunju AT, Olagunju TO, Oluwasanu MM, Omonisi AE, Onwujekwe OE, Oommen AM, Oren E, Ortega-Altamirano DDV, Ota E, Otstavnov SS, Owolabi MO, P A M, Padubidri JR, Pakhale S, Pakpour AH, Pana A, Park EK, Parsian H, Pashaei T, Patel S, Patil ST, Pennini A, Pereira DM, Piccinelli C, Pillay JD, Pirestani M, Pishgar F, Postma MJ, Pourjafar H, Pourmalek F, Pourshams A, Prakash S, Prasad N, Qorbani M, Rabiee M, Rabiee N, Radfar A, Rafiei A, Rahim F, Rahimi M, Rahman MA, Rajati F, Rana SM, Raoofi S, Rath GK, Rawaf DL, Rawaf S, Reiner RC, Renzaho AMN, Rezaei N, Rezapour A, Ribeiro AI, Ribeiro D, Ronfani L, Roro EM, Roshandel G, Rostami A, Saad RS, Sabbagh P, Sabour S, Saddik B, Safiri S, Sahebkar A, Salahshoor MR, Salehi F, Salem H, Salem MR, Salimzadeh H, Salomon JA, Samy AM, Sanabria J, Santric Milicevic MM, Sartorius B, Sarveazad A, Sathian B, Satpathy M, Savic M, Sawhney M, Sayyah M, Schneider IJC, Schöttker B, Sekerija M, Sepanlou SG, Sepehrimanesh M, Seyedmousavi S, Shaahmadi F, Shabaninejad H, Shahbaz M, Shaikh MA, Shamshirian A, Shamsizadeh M, Sharafi H, Sharafi Z, Sharif M, Sharifi A, Sharifi H, Sharma R, Sheikh A, Shirkoohi R, Shukla SR, Si S, Siabani S, Silva DAS, Silveira DGA, Singh A, Singh JA, Sisay S, Sitas F, Sobngwi E, Soofi M, Soriano JB, Stathopoulou V, Sufiyan MB, Tabarés-Seisdedos R, Tabuchi T, Takahashi K, Tamtaji OR, Tarawneh MR, Tassew SG, Taymoori P, Tehrani-Banihashemi A, Temsah MH, Temsah O, Tesfay BE, Tesfay FH, Teshale MY, Tessema GA, Thapa S, Tlaye KG, Topor-Madry R, Tovani-Palone MR, Traini E, Tran BX, Tran KB, Tsadik AG, Ullah I, Uthman OA, Vacante M, Vaezi M, Varona Pérez P, Veisani Y, Vidale S, Violante FS, Vlassov V, Vollset SE, Vos T, Vosoughi K, Vu GT, Vujcic IS, Wabinga H, Wachamo TM, Wagnew FS, Waheed Y, Weldegebreal F, Weldesamuel GT, Wijeratne T, Wondafrash DZ, Wonde TE, Wondmieneh AB, Workie HM, Yadav R, Yadegar A, Yadollahpour A, Yaseri M, Yazdi-Feyzabadi V, Yeshaneh A, Yimam MA, Yimer EM, Yisma E, Yonemoto N, Younis MZ, Yousefi B, Yousefifard M, Yu C, Zabeh E, Zadnik V, Moghadam TZ, Zaidi Z, Zamani M, Zandian H, Zangeneh A, Zaki L, Zendehdel K, Zenebe ZM, Zewale TA, Ziapour A, Zodpey S, Murray CJL.

JAMA Oncol. 2019 Sep 27. doi: 10.1001/jamaoncol.2019.2996. [Epub ahead of print]

4.

Correction to: Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3.

Kazemian E, Amouzegar A, Akbari ME, Moradi N, Gharibzadeh S, Jamshidi-Naeini Y, Khademolmele M, As'habi A, Davoodi SH.

Lipids Health Dis. 2019 Sep 14;18(1):174. doi: 10.1186/s12944-019-1110-8.

5.

Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study.

Khodabakhshi A, Akbari ME, Mirzaei HR, Mehrad-Majd H, Kalamian M, Davoodi SH.

Nutr Cancer. 2019 Sep 9:1-8. doi: 10.1080/01635581.2019.1650942. [Epub ahead of print]

PMID:
31496287
6.

Dietary Carbohydrate Promotes Cell Survival in Cancer Via the Up-Regulation of Fat Mass and Obesity-Associated Gene Expression Level.

Doaei S, Gholamalizadeh M, Akbari ME, Akbari S, Feradova H, Rahimzadeh G, Mosavi Jarrahi A.

Malays J Med Sci. 2019 Mar;26(2):8-17. doi: 10.21315/mjms2019.26.2.2. Epub 2019 Apr 30. Review.

7.

Vitamin D receptor gene polymorphisms affecting changes in visceral fat, waist circumference and lipid profile in breast cancer survivors supplemented with vitamin D3.

Kazemian E, Amouzegar A, Akbari ME, Moradi N, Gharibzadeh S, Jamshidi-Naeini Y, Khademolmele M, As'habi A, Davoodi SH.

Lipids Health Dis. 2019 Aug 9;18(1):161. doi: 10.1186/s12944-019-1100-x. Erratum in: Lipids Health Dis. 2019 Sep 14;18(1):174.

8.

Associations of demographic, socioeconomic, self-rated health, and metastasis in colorectal cancer in Iran.

Taheri M, Tavakol M, Esmaeil Akbari M, Almasi-Hashiani A, Abbasi M.

Med J Islam Repub Iran. 2019 Mar 13;33:17. doi: 10.34171/mjiri.33.17. eCollection 2019.

9.

Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model.

Hafizi M, Soleimani M, Noorian S, Kalanaky S, Fakharzadeh S, Tavakolpoor Saleh N, Nazaran MH, Akbari ME.

Onco Targets Ther. 2019 Jun 18;12:4691-4701. doi: 10.2147/OTT.S200446. eCollection 2019.

10.

Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.

Kazemian E, Akbari ME, Moradi N, Gharibzadeh S, Mondul AM, Jamshidi-Naeini Y, Khademolmele M, Zarins KR, Ghodoosi N, Amouzegar A, Davoodi SH, Rozek LS.

Nutrients. 2019 Jun 4;11(6). pii: E1264. doi: 10.3390/nu11061264.

11.

The Association between Dietary Patterns and Breast Cancer Pathobiological Factors Progesterone Receptor (PR) and Estrogen Receptors (ER): New Findings from Iranian Case-Control Study.

Sadeghi M, Vahid F, Rahmani D, Akbari ME, Davoodi SH.

Nutr Cancer. 2019;71(8):1290-1298. doi: 10.1080/01635581.2019.1602658. Epub 2019 Apr 22.

PMID:
31007067
12.

A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patients.

Hafizi M, Kalanaky S, Moaiery H, Khayamzadeh M, Noorian S, Kaveh V, Gharib B, Foudazi H, Razavi M, Jenabian A, Salimi S, Sereshki MMA, Mirzaei HR, Zarghi A, Fakharzadeh S, Nazaran MH, Akbari ME.

J Nanobiotechnology. 2019 Apr 10;17(1):52. doi: 10.1186/s12951-019-0484-0.

13.

The Vitamins Involved in One-Carbon Metabolisms are Associated with Reduced Risk of Breast Cancer in Overall and Subtypes.

Hatami M, Vahid F, Esmaeil Akbari M, Sadeghi M, Ameri F, Eini-Zeinab H, Jamshidi-Naeini Y, Hossein Davoodi S.

Int J Vitam Nutr Res. 2019 Feb 13:1-10. doi: 10.1024/0300-9831/a000501. [Epub ahead of print]

PMID:
30758268
14.

Socio-Economic Status Inequity in Self Rated Health in Patients with Breast Cancer.

Taheri M, Tavakol M, Akbari ME, Mohammadbeigi A, Abbasi M.

Open Access Maced J Med Sci. 2019 Jan 14;7(1):152-156. doi: 10.3889/oamjms.2019.028. eCollection 2019 Jan 15.

15.

Determinants of survival of common childhood cancers in Iran.

Keramatinia A, Mohseny M, Akbari ME, Mosavi-Jarrahi A, Monfared ED, Amanpour F, Bahadori Monfared A, Amiri P, Khayamzadeh M, Khoshbin Khoshnazar TA, Abbaszadeh HA, Mehrvar A, Mazloumi Z, Movafagh A.

J Res Med Sci. 2018 Nov 28;23:101. doi: 10.4103/jrms.JRMS_835_17. eCollection 2018.

16.

Probiotics and their role in gastrointestinal cancers prevention and treatment; an overview.

Javanmard A, Ashtari S, Sabet B, Davoodi SH, Rostami-Nejad M, Esmaeil Akbari M, Niaz A, Mortazavian AM.

Gastroenterol Hepatol Bed Bench. 2018 Fall;11(4):284-295. Review.

17.

Survival probability and prognostic factors of Iranian breast cancer patients using cure rate model.

Meshkat M, Baghestani AR, Zayeri F, Khayamzadeh M, Akbari ME.

Breast J. 2018 Nov;24(6):1015-1018. doi: 10.1111/tbj.13120. Epub 2018 Sep 30.

PMID:
30270522
18.

The roles of DNA epigenetics and clinical significance in Chronic Myeloid Leukemia: a review.

Keramatinia A, Ahadi A, Akbari ME, Mohseny M, Mosavi Jarahi A, Bahadori-Monfared A, Hashemi M, Moradi A, Mehrvar N, Kazemi E, Movafagh A.

Cell Mol Biol (Noisy-le-grand). 2018 Jun 30;64(9):58-63. Review.

PMID:
30030958
19.

Stimulatory Effect of Indolic Hormone on As2O3 Cytotoxicity in Breast Cancer Cells: NF-κB-dependent Mechanism of Action of Melatonin.

Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Bashash D, Nooshinfar E, Anjam-Najmedini A, Sadeghi S, Rezaie-Tavirani M, Akbari ME.

Int J Mol Cell Med. 2018 Summer;7(3):158-168. doi: 10.22088/IJMCM.BUMS.7.3.158. Epub 2018 Oct 14.

20.

Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data

Baghestani AR, Shahmirzalou P, Sayad S, Akbari ME, Zayeri F.

Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1601-1606.

21.

Effecst of Patho- Biological Factors on the Survival of Recurrent Breast Cancer Cases

Akbari ME, Rohani- Rasaf M, Nafissi N, Akbari A, Shojaee L.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):949-953.

22.

Psychological consideration in patients with cerebral gliomas candidates for intra-operative radiation therapy based on tumor location.

Seddighi A, Akbari ME, Seddighi AS, Nikouei A.

Hell J Nucl Med. 2017 Sep-Dec;20 Suppl:20-24.

PMID:
29324911
23.

Breast Cancer Status in Iran: Statistical Analysis of 3010 Cases between 1998 and 2014.

Akbari ME, Sayad S, Sayad S, Khayamzadeh M, Shojaee L, Shormeji Z, Amiri M.

Int J Breast Cancer. 2017;2017:2481021. doi: 10.1155/2017/2481021. Epub 2017 Nov 1.

24.

The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.

Ariana M, Arabi N, Pornour M, Vaseghi H, Ganji SM, Alivand MR, Salari M, Akbari ME.

J Cell Biochem. 2018 Feb;119(2):2168-2178. doi: 10.1002/jcb.26378. Epub 2017 Oct 30.

PMID:
28857238
25.

Application of Human Acellular Breast Dermal Matrix (ABDM) in Implant-Based Breast Reconstruction: An Experimental Study.

Nafisi N, Akbari ME, Mahjoub F, Mohseni MJ, Sabetkish S, Khorramirouz R, Tehrani M, Kajbafzadeh AM.

Aesthetic Plast Surg. 2017 Dec;41(6):1435-1444. doi: 10.1007/s00266-017-0931-y. Epub 2017 Jul 14.

PMID:
28710505
26.

Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach.

Keramatinia A, Ahadi A, Akbari ME, Mohseny M, Jarahi AM, Mehrvar N, Mansouri N, Tabatabaei SAM, Movafagh A.

J Cancer Prev. 2017 Jun;22(2):74-81. doi: 10.15430/JCP.2017.22.2.74. Epub 2017 Jun 30. Review.

27.

Comprehensive analysis of Iranian reports of pediatric central nervous system tumors.

Mehrvar N, Mehrvar A, Akbari ME, Qaddoumi I.

Childs Nerv Syst. 2017 Sep;33(9):1481-1490. doi: 10.1007/s00381-017-3468-0. Epub 2017 May 29.

28.

Breast cancer screening (BCS) chart: a basic and preliminary model for making screening mammography more productive and efficient.

Poorolajal J, Akbari ME, Ziaee F, Karami M, Ghoncheh M.

J Public Health (Oxf). 2018 Jun 1;40(2):e118-e125. doi: 10.1093/pubmed/fdx052.

PMID:
28505346
29.

Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.

Saemi N, Khoshnevis J, Akbari ME, Meysamie A, Korourian A, Gholizadeh B, Larijani L, Moradi A, Baikpour M, Baikpour M, Zham H.

J Gastrointest Cancer. 2018 Mar;49(1):35-40. doi: 10.1007/s12029-016-9905-6.

PMID:
27975182
30.

Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis.

Taghavi A, Akbari ME, Hashemi-Bahremani M, Nafissi N, Khalilnezhad A, Poorhosseini SM, Hashemi-Gorji F, Yassaee VR.

Oncol Lett. 2016 Nov;12(5):3845-3855. Epub 2016 Sep 30.

31.

Parameter estimation of breast tumour using dynamic neural network from thermal pattern.

Saniei E, Setayeshi S, Akbari ME, Navid M.

J Adv Res. 2016 Nov;7(6):1045-1055. Epub 2016 Jun 3.

32.

Structural Challenges of Providing Palliative Care for Patients with Breast Cancer.

Khoshnazar TA, Rassouli M, Akbari ME, Lotfi-Kashani F, Momenzadeh S, Haghighat S, Sajjadi M.

Indian J Palliat Care. 2016 Oct-Dec;22(4):459-466.

33.

Communication Needs of Patients with Breast Cancer: A Qualitative Study.

Khoshnazar TA, Rassouli M, Akbari ME, Lotfi-Kashani F, Momenzadeh S, Rejeh N, Mohseny M.

Indian J Palliat Care. 2016 Oct-Dec;22(4):402-409.

34.

Vitamin D Status and Risk of Breast Cancer in Iranian Women: A Case-Control Study.

Jamshidinaeini Y, Akbari ME, Abdollahi M, Ajami M, Davoodi SH.

J Am Coll Nutr. 2016 Sep-Oct;35(7):639-646. Epub 2016 Jun 22.

PMID:
27331363
35.

Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer.

Nooshinfar E, Bashash D, Safaroghli-Azar A, Bayati S, Rezaei-Tavirani M, Ghaffari SH, Akbari ME.

Biomed Pharmacother. 2016 Oct;83:456-465. doi: 10.1016/j.biopha.2016.07.004. Epub 2016 Jul 16.

PMID:
27427852
36.

Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?

Tabarestani S, Motallebi M, Akbari ME.

Iran J Cancer Prev. 2016 Aug 13;9(4):e6565. eCollection 2016 Aug. Review.

37.

Malignant Tumors of Tongue in Iranian Population.

Akbari ME, Atarbashi Moghadam S, Atarbashi Moghadam F, Bastani Z.

Iran J Cancer Prev. 2016 Aug 15;9(4):e4467. eCollection 2016 Aug.

38.

Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.

Poorolajal J, Nafissi N, Akbari ME, Mahjub H, Esmailnasab N, Babaee E.

Arch Iran Med. 2016 Oct;19(10):680-686.

39.

Cancer Screening, Effective or Harmful?

Esmaeil Akbari M.

Iran J Cancer Prev. 2016 Jun 29;9(3):e7616. eCollection 2016 Jun. No abstract available.

40.

Cancer Screening, Effective or Harmful?

Esmaeil Akbari M.

Iran J Cancer Prev. 2016 Apr 27;9(2):e6633. doi: 10.17795/ijcp-6633. eCollection 2016 Apr. No abstract available.

41.

The Islamic Perspective of Spiritual Intervention Effectiveness on Bio-Psychological Health Displayed by Gene Expression in Breast Cancer Patients.

Hosseini L, Lotfi Kashani F, Akbari S, Akbari ME, Sarafraz Mehr S.

Iran J Cancer Prev. 2016 Apr 27;9(2):e6360. doi: 10.17795/ijcp-6360. eCollection 2016 Apr.

42.

Health Manpower Development (HMD) Corner Stone of Improving National Health System.

Akbari ME.

Iran J Cancer Prev. 2016 Feb 23;9(1):e5625. doi: 10.17795/ijcp-5625. eCollection 2016 Feb. No abstract available.

43.

Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.

Haghighat S, Akbari ME, Yavari P, Javanbakht M, Ghaffari S.

Iran J Cancer Prev. 2016 Feb 23;9(1):e5443. doi: 10.17795/ijcp-5443. eCollection 2016 Feb.

44.

Incidence and Survival in Breast Cancer Patients and Stressful Life Events.

Fallah R, Akbari ME, Azargashb E, Khayamzadeh E.

Asian Pac J Cancer Prev. 2016;17(S3):245-52.

45.

Estimating Completeness of Cancer Registration in Iran with Capture-Recapture Methods.

Mohammadi G, Akbari ME, Mehrabi Y, Ghanbari Motlagh A, Partovi Pour E, Roshandel G, Khosravi A.

Asian Pac J Cancer Prev. 2016;17(S3):93-9.

46.

Melatonin, an inhibitory agent in breast cancer.

Nooshinfar E, Safaroghli-Azar A, Bashash D, Akbari ME.

Breast Cancer. 2017 Jan;24(1):42-51. doi: 10.1007/s12282-016-0690-7. Epub 2016 Mar 26. Review.

PMID:
27017208
47.

Development of a new method for sampling and monitoring oncology staff exposed to cyclophosphamide drug.

Panahi D, Azari M, Akbari ME, Zendehdel R, Mirzaei HR, Hatami H, Mehrabi Y.

Environ Monit Assess. 2016 Apr;188(4):238. doi: 10.1007/s10661-016-5255-x. Epub 2016 Mar 22.

PMID:
27003403
48.

Health Manpower Development (HMD) Corner Stone of Improving National Health System.

Akbari ME.

Iran J Cancer Prev. 2015 Dec;8(6):e5005. doi: 10.17795/ijcp-5005. Epub 2015 Dec 23. No abstract available.

49.

Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study.

Akbari ME, Bastani Z, Mokhtari S, Atarbashi Moghadam S.

Iran J Cancer Prev. 2015 Dec;8(6):e4124. doi: 10.17795/ijcp-4124. Epub 2015 Dec 23.

50.

BCc1, the novel antineoplastic nanocomplex, showed potent anticancer effects in vitro and in vivo.

Kalanaky S, Hafizi M, Fakharzadeh S, Vasei M, Langroudi L, Janzamin E, Hashemi SM, Khayamzadeh M, Soleimani M, Akbari ME, Nazaran MH.

Drug Des Devel Ther. 2015 Dec 30;10:59-70. doi: 10.2147/DDDT.S89694. eCollection 2016.

Supplemental Content

Loading ...
Support Center